1. Introduction
1.1. Report Description
1.2. Research Methodology
1.2.1. Secondary Research
1.2.2. Primary Research

2. Executive Summary
2.1. Key Highlights

3. Market Overview
3.1. Introduction
3.1.1. Market Definition
3.1.2. Market Segmentation
3.2. Market Dynamics
3.2.1. Drivers
3.2.2. Restraints
3.2.3. Opportunities
3.2.3.1. Emerging Markets to Offer Lucrative Growth Opportunities

4. Market Analysis by Regions
4.1. North America (United States, Canada and Mexico)
4.1.1. United States Market States and Outlook (2014-2023)
4.1.2. Canada Market States and Outlook (2014-2023)
4.1.3. Mexico Market States and Outlook (2014-2023)
4.2. Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
4.2.1. Germany Market States and Outlook (2014-2023)
4.2.2. France Market States and Outlook (2014-2023)
4.2.3. UK Market States and Outlook (2014-2023)
4.2.4. Russia Market States and Outlook (2014-2023)
4.2.5. Italy Market States and Outlook (2014-2023)
4.2.6. Rest of Europe Market States and Outlook (2014-2023)
4.3. Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Rest of Asia-Pacific)
4.3.1. China Market States and Outlook (2014-2023)
4.3.2. Japan Market States and Outlook (2014-2023)
4.3.3. Korea Market States and Outlook (2014-2023)
4.3.4. India Market States and Outlook (2014-2023)
4.3.5. Rest of Asia-Pacific Market States and Outlook (2014-2023)
4.4. South America (Brazil, Argentina, Columbia and Rest of South America)
4.4.1. Brazil Market States and Outlook (2014-2023)
4.4.2. Argentina Market States and Outlook (2014-2023)
4.4.3. Columbia Market States and Outlook (2014-2023)
4.4.4. Rest of South America Market States and Outlook (2014-2023)
4.5. Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa and Rest of MEA)
4.5.1. Saudi Arabia Market States and Outlook (2014-2023)
4.5.2. UAE Market States and Outlook (2014-2023)
4.5.3. Egypt Market States and Outlook (2014-2023)
4.5.4. Nigeria Market States and Outlook (2014-2023)
4.5.5. South Africa Market States and Outlook (2014-2023)
4.5.6. Rest of MEA Market States and Outlook (2014-2023)

5. Generic Injectables Market, By Therapeutic Area
5.1. Introduction
5.2. Global Generic Injectables Sales, Revenue and Market Share by Therapeutic Area (2014-2018)
5.2.1. Global Generic Injectables Sales and Sales Share by Therapeutic Area (2014-2018)
5.2.2. Global Generic Injectables Revenue and Revenue Share by Therapeutic Area (2014-2018)
5.3. Oncology
5.3.1. Global Oncology Sales and Growth Rate (2014-2018)
5.4. Anaesthesia
5.4.1. Global Anaesthesia Sales and Growth Rate (2014-2018)
5.5. Anti-infectives
5.5.1. Global Anti-infectives Sales and Growth Rate (2014-2018)
5.6. Parenteral Nutrition
5.6.1. Global Parenteral Nutrition Sales and Growth Rate (2014-2018)
5.7. Cardiovascular
5.7.1. Global Cardiovascular Sales and Growth Rate (2014-2018)

6. Generic Injectables Market, By Distribution Channel
6.1. Introduction
6.2. Global Generic Injectables Sales, Revenue and Market Share by Distribution Channel (2014-2018)
6.2.1. Global Generic Injectables Sales and Sales Share by Distribution Channel (2014-2018)
6.2.2. Global Generic Injectables Revenue and Revenue Share by Distribution Channel (2014-2018)
6.3. Hospitals
6.3.1. Global Hospitals Sales and Growth Rate (2014-2018)
6.4. Retail Pharmacy Stores
6.4.1. Global Retail Pharmacy Stores Sales and Growth Rate (2014-2018)

7. Generic Injectables Market, By Region
7.1. Introduction
7.2. Global Generic Injectables Sales, Revenue and Market Share by Regions
7.2.1. Global Generic Injectables Sales by Regions (2014-2018)
7.2.2. Global Generic Injectables Revenue by Regions (2014-2018)
7.3. North America Generic Injectables by Countries
7.3.1. North America Generic Injectables Sales and Growth Rate (2014-2018)
7.3.2. North America Generic Injectables Revenue and Growth Rate (2014-2018)
7.3.3. North America Generic Injectables Sales by Countries (2014-2018)
7.3.4. North America Generic Injectables Revenue (Million USD) by Countries (2014-2018)
7.3.5. U.S.
7.3.5.1. United States Generic Injectables Sales and Growth Rate (2014-2018)
7.3.5.2. United States Generic Injectables Revenue (Millions USD) and Growth Rate (2014-2018)
7.3.6. Canada
7.3.6.1. Canada Generic Injectables Sales and Growth Rate (2014-2018)
7.3.6.2. Canada Generic Injectables Sales (Millions USD) and Growth Rate (2014-2018)
7.3.7. Mexico
7.3.7.1. Mexico Generic Injectables Sales and Growth Rate (2014-2018)
7.3.7.2. Mexico Generic Injectables Revenue (Millions USD) and Growth Rate (2014-2018)
7.4. Europe Generic Injectables by Countries
7.4.1. Europe Generic Injectables Sales and Growth Rate (2014-2018)
7.4.2. Europe Generic Injectables Revenue and Growth Rate (2014-2018)
7.4.3. Europe Generic Injectables Sales by Countries (2014-2018)
7.4.4. Europe Generic Injectables Revenue (Million USD) by Countries (2014-2018)
7.4.5. Germany
7.4.5.1. Germany Generic Injectables Sales and Growth Rate (2014-2018)
7.4.5.2. Germany Generic Injectables Revenue (Millions USD) and Growth Rate (2014-2018)
7.4.6. UK
7.4.6.1. UK Generic Injectables Sales and Growth Rate (2014-2018)
7.4.6.2. UK Generic Injectables Revenue (Millions USD) and Growth Rate (2014-2018)
7.4.7. France
7.4.7.1. France Generic Injectables Sales and Growth Rate (2014-2018)
7.4.7.2. France Generic Injectables Revenue (Millions USD) and Growth Rate (2014-2018)
7.4.8. Russia
7.4.8.1. Russia Generic Injectables Sales and Growth Rate (2014-2018)
7.4.8.2. Russia Generic Injectables Revenue (Millions USD) and Growth Rate (2014-2018)
7.4.9. Italy
7.4.9.1. Italy Generic Injectables Sales and Growth Rate (2014-2018)
7.4.9.2. Italy Generic Injectables Revenue (Millions USD) and Growth Rate (2014-2018)
7.4.10. Rest of Europe
7.4.10.1. Rest of Europe Generic Injectables Sales and Growth Rate (2014-2018)
7.4.10.2. Rest of Europe Generic Injectables Revenue (Millions USD) and Growth Rate (2014-2018)
7.5. Asia-Pacific
7.5.1. Asia-Pacific Generic Injectables Sales and Growth Rate (2014-2018)
7.5.2. Asia-Pacific Generic Injectables Revenue and Growth Rate (2014-2018)
7.5.3. Asia-Pacific Generic Injectables Sales by Countries (2014-2018)
7.5.4. Asia-Pacific Generic Injectables Revenue (Million USD) by Countries (2014-2018)
7.5.5. China
7.5.5.1. China Generic Injectables Sales and Growth Rate (2014-2018)
7.5.5.2. China Generic Injectables Revenue (Millions USD) and Growth Rate (2014-2018)
7.5.6. Japan
7.5.6.1. Japan Generic Injectables Sales and Growth Rate (2014-2018)
7.5.6.2. Japan Generic Injectables Revenue (Millions USD) and Growth Rate (2014-2018)
7.5.6.3.
7.5.7. Korea
7.5.7.1. Korea Generic Injectables Sales and Growth Rate (2014-2018)
7.5.7.2. Korea Generic Injectables Revenue (Millions USD) and Growth Rate (2014-2018)
7.5.8. India
7.5.8.1. India Generic Injectables Sales and Growth Rate (2014-2018)
7.5.8.2. India Generic Injectables Revenue (Millions USD) and Growth Rate (2014-2018)
7.5.9. Southeast Asia
7.5.9.1. Southeast Asia Generic Injectables Sales and Growth Rate (2014-2018)
7.5.9.2. Southeast Asia Generic Injectables Revenue (Millions USD) and Growth Rate (2014-2018)
7.5.10. Rest of Asia-Pacific
7.5.10.1. Rest of Asia-Pacific Generic Injectables Sales and Growth Rate (2014-2018)
7.5.10.2. Rest of Asia-Pacific Generic Injectables Revenue (Millions USD) and Growth Rate (2014-2018)
7.6. South America
7.6.1. South America Generic Injectables Sales and Growth Rate (2014-2018)
7.6.2. South America Generic Injectables Revenue and Growth Rate (2014-2018)
7.6.3. South America Generic Injectables Sales by Countries (2014-2018)
7.6.4. South America Generic Injectables Revenue (Million USD) by Countries (2014-2018)
7.6.5. Brazil
7.6.5.1. Brazil Generic Injectables Sales and Growth Rate (2014-2018)
7.6.5.2. Brazil Generic Injectables Revenue (Millions USD) and Growth Rate (2014-2018)
7.6.6. Argentina
7.6.6.1. Argentina Generic Injectables Sales and Growth Rate (2014-2018)
7.6.6.2. Argentina Generic Injectables Revenue (Millions USD) and Growth Rate (2014-2018)
7.6.7. Columbia
7.6.7.1. Columbia Generic Injectables Sales and Growth Rate (2014-2018)
7.6.7.2. Columbia Generic Injectables Revenue (Millions USD) and Growth Rate (2014-2018)
7.6.8. Rest of South America
7.6.8.1. Rest of South America Generic Injectables Sales and Growth Rate (2014-2018)
7.6.8.2. Rest of South America Generic Injectables Revenue (Millions USD) and Growth Rate (2014-2018)
7.7. Middle East and Africa
7.7.1. Middle East and Africa Generic Injectables Sales and Growth Rate (2014-2018)
7.7.2. Middle East and Africa Generic Injectables Revenue and Growth Rate (2014-2018)
7.7.3. Middle East and Africa Generic Injectables Sales by Countries (2014-2018)
7.7.4. Middle East and Africa Generic Injectables Revenue (Million USD) by Countries (2014-2018)
7.7.5. Saudi Arabia
7.7.5.1. Saudi Arabia Generic Injectables Sales and Growth Rate (2014-2018)
7.7.5.2. Saudi Arabia Generic Injectables Revenue (Millions USD) and Growth Rate (2014-2018)
7.7.6. United Arab Emirates
7.7.6.1. United Arab Emirates Generic Injectables Sales and Growth Rate (2014-2018)
7.7.6.2. United Arab Emirates Generic Injectables Revenue (Millions USD) and Growth Rate (2014-2018)
7.7.7. Egypt
7.7.7.1. Egypt Generic Injectables Sales and Growth Rate (2014-2018)
7.7.7.2. Egypt Generic Injectables Revenue (Millions USD) and Growth Rate (2014-2018)
7.7.8. Nigeria
7.7.8.1. Nigeria Generic Injectables Sales and Growth Rate (2014-2018)
7.7.8.2. Nigeria Generic Injectables Revenue (Millions USD) and Growth Rate (2014-2018)
7.7.9. South Africa
7.7.9.1. South Africa Generic Injectables Sales and Growth Rate (2014-2018)
7.7.9.2. South Africa Generic Injectables Revenue (Millions USD) and Growth Rate (2014-2018)
7.7.10. Rest of Middle East and Africa
7.7.10.1. Rest of Middle East and Africa Generic Injectables Sales and Growth Rate (2014-2018)
7.7.10.2. Rest of Middle East and Africa Generic Injectables Revenue (Millions USD) and Growth Rate (2014-2018)

8. Company Profiles
8.1. Baxter
8.1.1. Business Overview
8.1.2. Product Portfolio
8.1.3. Strategic Developments
8.1.4. Sales, Revenue and Market Share
8.2. Fresenius Kabi
8.2.1. Business Overview
8.2.2. Product Portfolio
8.2.3. Strategic Developments
8.2.4. Sales, Revenue and Market Share
8.3. Hikma
8.3.1. Business Overview
8.3.2. Product Portfolio
8.3.3. Strategic Developments
8.3.4. Sales, Revenue and Market Share
8.4. Hospira (Pfizer)
8.4.1. Business Overview
8.4.2. Product Portfolio
8.4.3. Strategic Developments
8.4.4. Sales, Revenue and Market Share
8.5. Sagent
8.5.1. Business Overview
8.5.2. Product Portfolio
8.5.3. Strategic Developments
8.5.4. Sales, Revenue and Market Share
8.6. Sandoz (Novartis)
8.6.1. Business Overview
8.6.2. Product Portfolio
8.6.3. Strategic Developments
8.6.4. Sales, Revenue and Market Share
8.7. Sanofi
8.7.1. Business Overview
8.7.2. Product Portfolio
8.7.3. Strategic Developments
8.7.4. Sales, Revenue and Market Share

9. Global Generic Injectables Market Competition, by Manufacturer
9.1. Global Generic Injectables Sales and Market Share by Manufacturer (2016-2017)
9.2. Global Generic Injectables Revenue and Market Share by Manufacturer (2016-2017)
9.3. Global Generic Injectables Price by Manufacturer (2016-2017)
9.4. Top 5 Generic Injectables Manufacturer Market Share
9.5. Market Competition Trend

10. Generic Injectables Market Forecast (2018-2023)
10.1. Global Generic Injectables Sales, Revenue (Millions USD) and Growth Rate (2018-2023)
10.2. Generic Injectables Market Forecast by Regions (2018-2023)
10.2.1. North America Generic Injectables Market Forecast (2018-2023)
10.2.1.1. United States Generic Injectables Market Forecast (2018-2023)
10.2.1.2. Canada Generic Injectables Market Forecast (2018-2023)
10.2.1.3. Mexico Generic Injectables Market Forecast (2018-2023)
10.2.2. Europe Generic Injectables Market Forecast (2018-2023)
10.2.2.1. Germany Generic Injectables Market Forecast (2018-2023)
10.2.2.2. United Kingdom Generic Injectables Market Forecast (2018-2023)
10.2.2.3. France Generic Injectables Market Forecast (2018-2023)
10.2.2.4. Russia Generic Injectables Market Forecast (2018-2023)
10.2.2.5. Italy Generic Injectables Market Forecast (2018-2023)
10.2.2.6. Rest of the Europe Generic Injectables Market Forecast (2018-2023)
10.2.3. Asia-Pacific Generic Injectables Market Forecast (2018-2023)
10.2.3.1. China Generic Injectables Market Forecast (2018-2023)
10.2.3.2. Japan Generic Injectables Market Forecast (2018-2023)
10.2.3.3. Korea Generic Injectables Market Forecast (2018-2023)
10.2.3.4. India Generic Injectables Market Forecast (2018-2023)
10.2.3.5. Southeast Asia Generic Injectables Market Forecast (2018-2023)
10.2.3.6. Rest of Asia-Pacific Generic Injectables Market Forecast (2018-2023)
10.2.4. South America Generic Injectables Market Forecast (2018-2023)
10.2.4.1. Brazil Generic Injectables Market Forecast (2018-2023)
10.2.4.2. Argentina Generic Injectables Market Forecast (2018-2023)
10.2.4.3. Columbia Generic Injectables Market Forecast (2018-2023)
10.2.4.4. Rest of South America Generic Injectables Market Forecast (2018-2023)
10.2.5. Middle East and Africa Generic Injectables Market Forecast (2018-2023)
10.2.5.1. Saudi Arabia Generic Injectables Market Forecast (2018-2023)
10.2.5.2. UAE Generic Injectables Market Forecast (2018-2023)
10.2.5.3. Egypt Generic Injectables Market Forecast (2018-2023)
10.2.5.4. Nigeria Generic Injectables Market Forecast (2018-2023)
10.2.5.5. South Africa Generic Injectables Market Forecast (2018-2023)
10.2.5.6. Rest of MEA Generic Injectables Market Forecast (2018-2023)
10.3. Generic Injectables Market Forecast by Therapeutic Area (2018-2023)
10.3.1. Global Generic Injectables Sales Forecast by Therapeutic Area (2018-2023)
10.3.2. Global Generic Injectables Sales Market Share Forecast by Therapeutic Area (2018-2023)
10.4. Generic Injectables Market Forecast by Distribution Channel (2018-2023)
10.4.1. Global Generic Injectables Sales Forecast by Distribution Channel (2018-2023)
10.4.2. Global Generic Injectables Sales Market Share Forecast by Distribution Channel (2018-2023)